tiprankstipranks
Advertisement
Advertisement
Inovio files $300M mixed securities shelf
PremiumThe FlyInovio files $300M mixed securities shelf
1M ago
Inovio price target lowered to $2.50 from $3 at H.C. Wainwright
Premium
The Fly
Inovio price target lowered to $2.50 from $3 at H.C. Wainwright
2M ago
Inovio: ApolloBio announces ‘positive’ results from Phase 3 trial of VGX-3100
Premium
The Fly
Inovio: ApolloBio announces ‘positive’ results from Phase 3 trial of VGX-3100
2M ago
Inovio options imply 15.1% move in share price post-earnings
PremiumThe FlyInovio options imply 15.1% move in share price post-earnings
3M ago
Options Volatility and Implied Earnings Moves Today, May 13, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, May 13, 2026
3M ago
Options Volatility and Implied Earnings Moves This Week, May 11 – May 14, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, May 11 – May 14, 2026
3M ago
Shareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims
PremiumMarket NewsShareholders Sue Inovio Pharmaceuticals Over DNA Technology Claims
4M ago
Inovio’s Earnings Call: INO-3107 Drives 2026 Focus
Premium
Company Announcements
Inovio’s Earnings Call: INO-3107 Drives 2026 Focus
5M ago
Inovio Pharmaceuticals: Balancing INO-3107 Regulatory Uncertainty and Early-Stage Pipeline Potential Justifies Hold Rating and $3 Target
Premium
Ratings
Inovio Pharmaceuticals: Balancing INO-3107 Regulatory Uncertainty and Early-Stage Pipeline Potential Justifies Hold Rating and $3 Target
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100